Background: Inadequate volume control may be a main contributor to poor survival and high mortality in hemodialysis patients. Bioimpedance measurement has the potential to improve fluid management, but several dialysis centers lack an agreed fluid management policy, and the method has not yet been implemented. Our aim was to identify renal care professionals' perceived barriers and facilitators for use of bioimpedance in clinical practice. Methods: Qualitative data were collected through four focus group interviews with 24 renal care professionals: dieticians, nephrologists and nurses, recruited voluntarily from a nation-wide selection of hemodialysis centers, having access to a bioimpedance-device. The participants were connected to each other and a moderator via equipment for telemedicine and the sessions were recorded. The interviews were semi-structured, focusing on the participants' perceptions of use of bioimpedance in clinical practice. Thematic content analysis was performed in consecutive steps, and data were extracted by employing an inductive, interactive, comparative process. Results: Several barriers and facilitators to the use of bioimpedance in clinical practice were identified, and a multilevel approach to examining barriers and incentives for change was found to be applicable to the ideas and categories that arose from the data. The determinants were categorized on five levels, and the different themes of the levels illustrated with quotations from the focus groups participants. Conclusions: Determinants for use of bioimpedance were identified on five levels: 1) the innovation itself, 2) the individual professional, 3) the patient, 4) the social context and 5) the organizational context. Barriers were identified in the areas of credibility, awareness, knowledge, self-efficacy, care processes, organizational structures and regulations. Facilitators were identified in the areas of the innovation's attractiveness, advantages in practice, and collaboration. Motivation, team processes and organizational capacities appeared as both barriers and facilitators.
Background
Assessing hydration status and achieving an adequate dry weight in dialysis patients is a delicate task; morbidity and mortality, primarily due to cardiovascular disease, remain unacceptably high, and emerging evidence suggests inadequate volume control as a main contributor [1] [2] [3] . A golden standard for dry weight assessment is absent, and finding practical and reliable tools to ascertain dry weight is a prioritized research area [4, 5] .
Traditionally fluid volume status is based on clinical examination, but a number of technologies are now available to aid assessment [6, 7] . Bioimpedance is a non-invasive method that analyzes the electrical resistance and reactance of human tissue. Certain properties of the tissue can be measured: fluid overload, but also normally hydrated lean tissue mass and normally hydrated adipose tissue mass [8, 9] . In recent randomized controlled trials, regression of left ventricular mass index, decrease in blood pressure, improved arterial stiffness and improved survival were demonstrated in hemodialysis patients when bioimpedance spectroscopy was used to guide dry weight adjustments [10, 11] . However, although guidelines welcome novel technical investigations, and a growing body of studies advocates use of bioimpedance to guide dry weight adjustments, researchers exhort for caution when applying results from any technical tool [4, [12] [13] [14] [15] . The hemodialysis population consists of heterogeneous and often fragile patients, and since most studies selection criteria are restrictive; sicker patients such as those with implants, major amputation and those with life expectancy of less than one year are usually excluded, thus there are challenges in the clinical application of bioimpedance [16] [17] [18] [19] [20] . Crosssectional studies show that bioimpedance devices are available in several hemodialysis centers, but only about 25% of the units use it regularly in dry weight assessment, most units still lack established guidelines for clinical use of bioimpedance, hence access to a device is not necessarily associated with improved volume control. [21, 22] . For implementation of innovations to be successful, it is crucial to acquire a good understanding of the problem, the target group, its setting and the obstacles to change [23] [24] [25] . There is still very little information in published literature as to how well fluid volume management is done in practice and analysis of reasons for professionals not adopting new innovations. The aim of this study was to identify renal care professionals' perceived barriers and facilitators for use of bioimpedance in clinical practice.
Methods

Study design
The study has a qualitative explorative design. Data were collected through focus group interviews. The third step of the Grol and Wensing Implementation of Change Model, which involves problem analysis of the target group and setting, was used as a theoretical framework [26] . The first two steps of the model involve determination of targets for improvement and assessment of the actual performance in practice, those steps were carried out by a previous study [21] .
Participants and setting
We planned for four focus groups with approximately six to eight participants in each group. Focus groups should offer homogeneity with sufficient variation among participants to allow for contrasting opinions [27] , thus individuals from a variety of professional backgrounds that may benefit from aid of bioimpedance in renal care -dieticians, nephrologists and nurses, were invited to participate in the study. Participants were recruited from a purposive selection of 13 hemodialysis units of different sizes; units with access to a bioimpedance device, but reporting different levels of use: frequent (n = 6), occasional (n = 3) or rare (n = 4) [21] , located in four Swedish regions, inhabiting 70% of the total population. The number of patients treated per unit range from below 20 to close to 200. Due to unavailability of participants for the interview dates two units dropped out, thus, in the final sample, four university hospital units (UHU), six county hospital units (CHU) and one satellite unit (SU) were represented. The included units employ 30 nephrologists and 240 nurses altogether, and in average one dietician per unit.
Presumptive participants received an invitation by e-mail with a short introduction to the study and the procedure of confidentiality, then the first line managers of the addressed units were asked to identify two volunteering renal nurses, whilst dieticians and nephrologists were recruited via national and regional networks. In total, 25 renal care professionals volunteered and gave informed consent to participate, although one nephrologist was later prevented from attending. As hierarchical structures and different levels of education may hinder participants from expressing their opinions [27, 28] , the physicians were gathered in a separate group, but for contrast, each focus group included participants from two to four different hospitals. In total, four sessions, each with four to nine participants, were conducted.
Data collection
A semi-structured questioning route was developed [27, 29, 30] . To evaluate the questioning route and technical facilities, two pilot interviews were conducted. The definitive main questions were:
-Describe how you use bioimpedance in your everyday practice -is it as you planned for? -What advantages or barriers have you experienced in practice? -How could use of bioimpedance be improved in your clinic?
An experienced qualitative researcher conducted the focus group interviews, and an assisting moderator was present in all sessions. The respondents gathered in conference rooms at their local hospitals and were connected to the other focus group participants and the moderator via equipment for telemedicine. They were informed that the moderator has a medical background, but no experience with hemodialysis care. Audio recording was used, and in three sessions visual recording was used too. Each session lasted approximately 30 min, and immediately following the interview sessions the records were transcribed verbatim.
Analysis
The transcripts were read through several times and coded for thematic content analysis in order to inductively derive concepts and core themes from the data. The analysis process was continual and performed in consecutive steps [27, 31, 32] (Fig. 1) . Quotations relating to the aim of the study were initially sorted into theoretical domains [30] . Next, within each theoretical domain, discrete concepts were identified to allow comparisons for similarities and differences, and a coding scheme was developed to permit connections between concepts.
In reflection on the discrete concepts identified and after review of the literature, a multilevel approach to examining barriers and incentives for change [23] was found to be applicable to the ideas and categories that arose from the data. The final step involved systematically relating core categories to other categories to extract barriers and facilitators that could influence use of bioimpedance on multiple levels. The first author performed the initial analysis and then the co-authors independently reviewed the interview transcripts to identify key words, phrases, and concepts used by the participants to enhance accuracy of the analysis. The research team discussed the results of the analysis until consensus was reached.
Results
Determinants for use of bioimpedance in hemodialysis were identified on five levels ( Table 1 ): 1) the innovation itself, 2) the individual professional, 3) the patient, 4) the social context and 5) the organizational context. The different themes of the levels are described and illustrated with quotations from the focus groups. Quotations are identified with the participant's profession and type of clinic. Table 2 presents descriptive data of the participants.
Innovation Barriers
Several users had been enthusiastic about bioimpedance initially, but expressed declining confidence in the method. If a result was not supported by clinical assessment or other methods for assessment of hydration status, it would be rejected. While individuals considered it a strength to possess a critical mindset, other participants feared assessment of measurement would be arbitrary. Evaluations of bioimpedance measurements on patients who were malnourished, amputees, non-Caucasians, children, body builders, patients with chromosomal abnormalities or with implants were particularly troublesome. Several participants were interested in using bioimpedance to assess nutritional status, but considered validation and reliability insufficient.
Credibility
In the beginning we had great faith in it [bioimpedance], and we adjusted the dry weight almost to the hectogram on what it showed, but then reality caught up with us. It turned out it didn't fit so well [...]. It hasn't been very useful recently. When a measurement is consistent with our assessment, we think it's correct, but when it isn't consistent with our perception, we don't rely on it. We've tried to use it to measure fat mass and fat-free mass, but we've found the reliability insufficient, so it hasn't been of any value. [Dietician, CHU]
Facilitators
Use of bioimpedance was associated with feelings of curiosity and excitement; it put dry weight determination on the agenda and provided new insights. Bioimpedance had been particularly helpful in identifying over Table 1 Overview of barriers and facilitators on five levels Categories:
Type [35, 56] Years in profession 8 [4, 11] 31 [25, 37] 14 [9, 19] 15 [8, 26] Years in current clinic 4 [1, 9] 19 [12, 25] 10 [3, 16] 11 [3, 16] hydration in cases of young, tall patients with severe hypertension but no visible signs of over hydration. Participants described satisfaction for being able to bring relief to patients by eliminating symptoms of under hydration by increasing dry weight by several kilograms with support of bioimpedance. Although some participants identified insufficient reliability regarding the measurement of nutritional status as a barrier, others found the ability to measure nutritional status an incentive for use, since they considered there were no other objective methods available. Software for visual imaging of changes in body composition over time in a graph was considered a helpful educational tool in interactions with patients. 
Advantages in practice
Individual professional Barriers
In several units, bioimpedance had not been introduced systematically or strategically, and the continual education was insufficient, lacking, or dependent on the interest or commitment of certain individuals. Since there was insufficient clarity regarding recommendations, study participants had different perceptions of the limitations and restrictions of use; e.g. some units used bioimpedance in patients with certain pacemakers while others stated that use of bioimpedance was incompatible with all pacemakers. Some nurses and dieticians expressed limited self-efficacy and feared that incorrect performance due to lack of skill and experience in measuring would contribute to misjudgment of hydration status. All professional groups repeatedly emphasized the importance of experience with assessing hydration status, and the urge not to rely on bioimpedance solely. Some nurses acknowledged lack of preexisting knowledge about the distribution of body fluids, especially when affected by malnutrition, inflammation and age, as a barrier for interpretation of the bioimpedance measurement. Some questioned whether bioimpedance could improve dry weight determination at all.
Awareness
I attended a lecture about these measurements, but then it had only been performed on non-kidney patients, but so I don't know if research has been performed in individuals with kidney disease.
[ 
Patients' input Barriers
Participants' perceptions were that only a minority of patients was reluctant to have their dry weight determined using bioimpedance, because the measurement did not support their own apprehension. A few respondents found that patients were unwilling to postpone start of hemodialysis treatment with approximately 15 min due to the recommendation to rest in a supine position before measurement. Some units did not recognize the delay as a problem since they did not follow the recommendation.
Knowledge
Some patients say no. They don't want to see it; they don't believe in it. 
Social context Barriers
Some nurses expressed frustration because physicians did not trust or follow up results. Use of bioimpedance thus felt meaningless.
Team process
Since it's not followed up, why bother measuring? Some doctors don't understand it and then they don't trust the results, and it's not followed up. 
In our unit, it is usually the nurses who measure on their own initiative. They are quite independent, determine dry weights and such, they consult us, the physicians only if they feel uncertain. And if they are uncertain, they usually run a BCM and then discuss with us, so it's usually their initiative.
Organizational context Barriers
One frequently mentioned barrier to use of bioimpedance was lack of structure. There were large variations in routines regarding when to use it, how to interpret results and how to follow up. Some units had guidelines for utilization, but due to high workloads and a shortage of trained staff, bioimpedance measurement was not a priority. Having to wait for the device if someone else was currently using it could interrupt workflow, but this barrier did not have a high impact on use.
To prevent the spread of infection, one patient with a multi-drug resistant infection had been isolated. Equipment brought to the room had been kept to a minimum; consequently, bioimpedance measurement had not been performed preventively, and the patient gradually developed pulmonary edema. 
Capacity
The problem is when nurses quit and are replaced; there will be new nurses. To do measurements, it takes some commitment and motivation, for it to be of any benefit. [Nephrologist, UHU] Some people prioritize other things. Going and getting a machine to measure might sometimes be met with resistance. As for now, with 24 extra patients and a shortage of six staff members, you have to set priorities, and it's not going to be bioimpedance measurement. [Nurse, UHU]
Care process
In our unit, sometimes -in the morning when starting the treatments it's quite hectic -the device is occupied, because it's used every day. So it's always in another room, and sometimes you may not want to wait the extra five minutes, so you start the treatment and you'll do the measurement the next time. That may be a reason why you skip it. [Nurse, CHU
Regulations
A patient was kept isolated due to a multi-drug resistant infection. He -without any known new infarction or so -began to develop pulmonary edema. It has been ten to twenty years since I experienced dialysis patients in that situation, but he had not been measured then. [Nephrologist, UHU]
Facilitators
Small units had higher capacity for organizational change. For example, participants from a satellite clinic described successful implementation of bioimpedance in clinical practice despite absence of written guidelines. 
Discussion
The importance of adequate fluid volume management in hemodialysis patients is well established, and a number of technologies are now available to aid assessment of fluid status of which bioimpedance spectroscopy has been most extensively studied [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . However, many dialysis centers lack an agreed fluid management policy, and studies show access to bioimpedance devices in the clinics may not have impact on practice patterns [21, 22] . An evident barrier for clinical use of bioimpedance, which may subjectively prohibit routine measurements, was professionals' perception of insufficient credibility; several participants of the focus groups found the method unreliable, due to inconsistent measurement results. However, all methods for assessment of hydration status perform best when measured serially and when performed in conjunction with other methods of volume assessment [7, [12] [13] [14] 33] , but not all study participants were aware of the importance of serial bioimpedance measurements. Users' questioning the underlying evidence is a known barrier for implementation, and as evidence often focuses on patients with single diseases and excludes complex patients, practical applicability may be limited. [34] [35] [36] .
In some clinics, use of bioimpedance in daily practice depended on individual initiatives. Bioimpedance had not been introduced strategically, but through passive dissemination of information, which is generally ineffective [24, 25, 37] . Thus, awareness of the potential benefits of bioimpedance [10, 11, 16, 18, 19] was insufficient. Recommendations for use of bioimpedance have changed over time [38] , but there were diverse opinions on how to use bioimpedance, e.g. in patients with a pacemaker, amputees, or for assessing nutritional status. These findings indicate the necessity of channels to provide new and updated research recommendations [24, 39, 40] .
Lack of collaboration between different types of professionals and deficient congruency in recommendations were perceived as barriers. Some nurses reported limited selfefficacy in using bioimpedance and interpreting the results due to lack of preexisting knowledge, but in units where dieticians contributed knowledge, participants expressed a higher degree of self-efficacy. Inter-professional collaboration may be critical to the provision of efficient health care and has the potential to increase self-efficacy [41] .
Some participants perceived patients' preference to start the hemodialysis session without delay as a barrier for using bioimpedance. However, as other participants denied that this was a barrier, professionals may also have misconceptions about patient values [30] . Software for visualization of bioimpedance results was found helpful in interactions with patients, and motivation and curiosity among well-informed patients were an incentive for use of bioimpedance [42, 43] .
Several participants in the focus groups, the physicians in particular, found the device attractive, as it had contributed to increased knowledge about hydration status and put the subject of dry weight on the agenda. Participants had experienced advantages in clinical practice and found patients to be motivated, resulting in the professionals' own motivation to change their practice. Attractiveness and experience of advantages in practice are characteristics considered crucial for successful implementation of an innovation [26] . Hence, implementation of bioimpedance in clinical practice has theoretically a good chance for success. However, in most units prime initiators of bioimpedance-measurement were nurses, and use of bioimpedance in the clinical setting was still dependent on certain individuals' personal interest and dedication. Although some units had developed routines for use of bioimpedance, measurement would not be a priority in periods of high workload and shortage of trained staff. This may indicate that many professionals do not consider bioimpedance a facilitator in daily practice, and interprofessional consensus is missing. Contextual factors, such as hospital size, may also influence successful implementation [44] , as the use of bioimpedance had been implemented successfully without systematic implementation strategies in small units.
Limitations
Due to the qualitative approach, we gained insight into perceived barriers and facilitators, although we cannot appraise the frequency of the identified determinants or their impact on the use of bioimpedance. In order to develop an implementation strategy on a national level or in other countries, a quantitative study on the frequency and impact of identified themes and concepts in this study, could contribute to increased transferability. To prevent inaccuracy in the results, we pilot-tested the questioning route, and used the same moderator in all interviews and for improved confirmability [45] , study reporting is based on a rich representation of quotations. Also, as the moderator and assisting moderator debriefed immediately after each session, a tendency to intellectualize [27] was identified in the first focus group, thus the questioning route could be adapted in order to make a clearer distinction between participants' intended behavior and the setting description.
A limitation of the study is that a selection bias might be inherent due to the strategy to recruit volunteer participants who can best supply information i.e. renal care professionals with experience of using bioimpedance, but whom might also be professionals with most favorable opinions. That is, professionals with unusual experiences and other perceptions might have been missed. There is also a risk, that the study participants' differences in age and years in profession may have biased the result. The choice to conduct interviews via equipment for telemedicine may have affected dependability, as some users were unaccustomed to the setting. On the other hand, use of telemedicine allowed for interviews with nationwide representatives. A multidisciplinary perspective, including a wide variety of professionals and different types of clinics enhanced credibility, but input from physicians and dieticians was limited due to the small number of participants. We therefore cannot fully assure that we reached saturation on all themes [27, 29] or that all potential perceptions from physicians and dieticians was materialized. However, our aim was not to compare and contrast differences between different professionals perception, and in order to enhance feasibility it is an accepted rule of thumb to plan for three or four interviews when using focus groups for data collection, since the analyst looks for patterns and themes across groups [27] . Moreover, the relative proportions of dieticians, nephrologists and nurses in the study sample do reflect the actuality of the study population well.
Conclusion
Bioimpedance may contribute valuable support to clinical assessment of hydration status in hemodialysis patients. In this qualitative study content analysis of focus groups interviews with renal care professionals was used to identify perceived barriers and facilitators for use of bioimpedance in clinical practice. A multilevel approach to examining barriers and incentives for change was found to be applicable to the ideas and categories that arose from the data, and determinants, either facilitating or preventing use of bioimpedance, were identified on five levels: 1) the innovation itself, 2) the individual professional, 3) the patient, 4) the social context and 5) the organizational context. Barriers for use were found in the areas of insufficient credibility, lack of awareness, insufficient knowledge, limited self-efficacy, lack of structure and contradictory regulations. However, implementation of bioimpedance have the potential to be successful, as several facilitating factors were found; such as attractiveness of the device and users' experiences of advantages in practice. Moreover, in units with inter-professional collaboration, participants expressed higher levels of knowledge and self-efficacy, which contributed to motivation to change practice.
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